Similar articles

• Screening for prostate cancer. How can patients give informed consent?

  Marshall KG. Marshall KG. Can Fam Physician. 1993 Nov;39:2385-90. Can Fam Physician. 1993. PMID: 7505673 Free PMC article.
• Informed consent. From bodily invasion to the seemingly mundane.

  Ubel PA. Ubel PA. Arch Intern Med. 1996 Jun 24;156(12):1262-3. doi: 10.1001/archinte.156.12.1262. Arch Intern Med. 1996. PMID: 8651833 No abstract available.
• Ethical issues in urology: the patient's perspective.

  Wilkie P. Wilkie P. Br J Urol. 1995 Nov;76 Suppl 2:5-7. doi: 10.1111/j.1464-410x.1995.tb07864.x. Br J Urol. 1995. PMID: 8535755 Review. No abstract available.
• The impact of informed consent on patient interest in prostate-specific antigen screening.

  Wolf AM, Nasser JF, Wolf AM, Schorling JB. Wolf AM, et al. Arch Intern Med. 1996 Jun 24;156(12):1333-6. Arch Intern Med. 1996. PMID: 8651843 Clinical Trial.
• Screening for prostate cancer in 2006: PSA in the 21st century.

  Maroni PD, Crawford ED. Maroni PD, et al. N C Med J. 2006 Mar-Apr;67(2):136-9. N C Med J. 2006. PMID: 16752718 Review. No abstract available.